EBS Emergent BioSolutions Inc. Common Stock
NYSE · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$6,33
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$4,3652-Wochen-Tief
$14,0652-Wochen-Hoch
Marktkapitalisierung (MRQ)
$325M
P/E (TTM)
-1.8
EPS (TTM)
$-3.46
Umsatz (TTM)
$770M
Ihre Abzeichen
52W-Spanne
$4–$14
Analystenbewertung
BUY
Kursziel
$11
P/E
-1.8
ROE
-40.3%
Nettogewinnmarge
-23.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
EBS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$6.33
Marktkapitalisierung (MRQ)
$325M
P/E (TTM)
-1.8
EPS (TTM)
$-3.46
Umsatz (TTM)
$770M
ROE (TTM)
-40.3%
Verschuldungsgrad (MRQ)
1.7
52W-Spanne
$4–$14
EBS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$743M2017-12-31 → 2025-12-31
EPS$0.932017-12-31 → 2025-12-31
Freier Cashflow$157M2017-12-31 → 2025-12-31
Nettogewinnmarge-23.0%2017-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | EBS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.85-Jahres-Durchschnitt ≈1.9 | ≈1.9 | · | · | |
| P/S (TTM) | 0.45-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 25.7 | Unterbewertet | |
| K/B (MRQ) | 1.05-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 2.5 | Unterbewertet | |
| EV / EBITDA | 3.65-Jahres-Durchschnitt ≈3612.0 | ≈3612.0 | · | · | |
| Kurs / FCF (TTM) | 3.85-Jahres-Durchschnitt ≈6.0 | ≈6.0 | · | · | |
| Kurs / Cashflow (TTM) | 3.35-Jahres-Durchschnitt ≈4.0 | ≈4.0 | · | · | |
| EV / Revenue (EV / Umsatz) | 0.95-Jahres-Durchschnitt ≈1.2 | ≈1.2 | · | · | |
| EV / FCF | 4.45-Jahres-Durchschnitt ≈10.6 | ≈10.6 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 4.15-Jahres-Durchschnitt ≈3.4 | ≈3.4 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | EBS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -8.6%5-Jahres-Durchschnitt ≈-20.3% | ≈-20.3% | -209.1% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 3.7%5-Jahres-Durchschnitt ≈-11.5% | ≈-11.5% | -209.1% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -19.0%5-Jahres-Durchschnitt ≈-23.0% | ≈-23.0% | -245.7% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -23.0%5-Jahres-Durchschnitt ≈-25.7% | ≈-25.7% | -246.0% | Spitzenklasse | |
| ROA (TTM) | -14.0%5-Jahres-Durchschnitt ≈-12.8% | ≈-12.8% | -49.3% | Spitzenklasse | |
| ROE (TTM) | -40.3%5-Jahres-Durchschnitt ≈-47.2% | ≈-47.2% | -64.8% | Spitzenklasse | |
| ROIC | 5.8%5-Jahres-Durchschnitt ≈-15.4% | ≈-15.4% | -100.1% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | EBS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 1.75-Jahres-Durchschnitt ≈1.5 | ≈1.5 | · | · | |
| Liquiditätsgrad (MRQ) | 5.45-Jahres-Durchschnitt ≈3.2 | ≈3.2 | 5.1 | Im Einklang | |
| Quick Ratio | 2.25-Jahres-Durchschnitt ≈1.4 | ≈1.4 | 2.9 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 1.75-Jahres-Durchschnitt ≈1.1 | ≈1.1 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | EBS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -28.8%5-Jahres-Durchschnitt ≈-18.1% | ≈-18.1% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -12.7%5-Jahres-Durchschnitt ≈-13.9% | ≈-13.9% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -14.0% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -30.4% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -29.7% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | EBS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.55-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.1 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 1.0 | · | · | · | |
| Receivables Turnover (Forderungsumschlag) | 6.25-Jahres-Durchschnitt ≈6.1 | ≈6.1 | 2.6 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$825.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
217.1%
Nächster Bericht
Okt 27, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 11, 2026 | $0.60 | $0.11 | 440.1% |
| 31. März 2026 | Mai 13, 2026 | $0.21 | $-0.25 | 183.2% |
| 31. Dezember 2025 | $-0.43 | $0.11 | -487.0% | |
| 30. September 2025 | $1.06 | $-0.12 | 974.6% | |
| 30. Juni 2025 | $0.16 | $-0.49 | 132.3% | |
| 31. März 2025 | $0.71 | $0.44 | 59.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Cost of Revenue | $326M | $681M | $705M | $693M | $748M | $537M | $434M | $322M | $188M | $126M | $107M | $102M | |
| Gross Profit | · | · | $318M | $383M | $891M | $925M | · | · | · | · | · | · | |
| R&D Expense | $53M | $71M | $111M | $188M | $235M | $238M | $226M | $143M | $97M | $107M | $119M | $105M | |
| SG&A Expense | $186M | $308M | $368M | $340M | $349M | $304M | $274M | $202M | $143M | $143M | $121M | $109M | |
| Operating Expenses | · | · | · | · | · | · | $992M | $693M | $437M | $383M | · | · | |
| Operating Income | $100M | $-109M | $-726M | $-170M | $341M | $438M | $114M | $90M | $124M | $106M | $142M | $89M | |
| Interest Expense | · | · | $88M | $37M | $34M | $31M | $38M | $10M | $7M | $8M | $7M | $8M | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $1M | $572.0K | $320.0K | |
| Other Non-op | $54M | $12M | $6M | $-12M | $-4M | $5M | $2M | $2M | $900.0K | $1M | $153.0K | $3M | |
| Pretax Income | $83M | $-143M | $-731M | $-219M | $303M | $412M | $77M | $82M | $119M | $99M | $136M | $84M | |
| Income Tax | $30M | $48M | $29M | $-7M | $84M | $106M | $23M | $19M | $36M | $37M | $44M | $30M | |
| Net Income | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| EPS (Basic) | $0.98 | $-3.60 | $-14.85 | $-4.22 | $4.10 | $5.80 | $1.06 | $1.25 | $1.98 | $1.29 | $1.63 | $0.98 | |
| EPS (Diluted) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 | |
| Shares (Basic) | 53,500,000 | 53,000,000 | 51,200,000 | 50,100,000 | 53,500,000 | 52,700,000 | 51,500,000 | 50,100,000 | 41,800,000 | 40,200,000 | 38,595,435 | 37,344,891 | |
| Shares (Diluted) | 56,700,000 | 53,000,000 | 51,200,000 | 50,100,000 | 54,100,000 | 53,800,000 | 52,400,000 | 51,400,000 | 50,300,000 | 49,300,000 | 47,255,842 | 45,802,807 | |
| EBITDA | $196M | $100.0K | $-601M | $-170M | $353M | $484M | $164M | $126M | $157M | $134M | $121M | $81M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $100M | $112M | $643M | $576M | $621M | $168M | $112M | $178M | $272M | $313M | $280M | |
| Receivables | $84M | $154M | $191M | $159M | $279M | $231M | $271M | $262M | $144M | $138M | $114M | $59M | |
| Inventory | $343M | $312M | $329M | $351M | $344M | $307M | $222M | $206M | $143M | $74M | $61M | $66M | |
| Prepaid Expense | $26M | $27M | $48M | $58M | $70M | $36M | $25M | $32M | $17M | $16M | $18M | $24M | |
| Current Assets | $662M | $599M | $680M | $1.21B | $1.27B | $1.20B | $686M | $621M | $485M | $510M | $537M | $432M | |
| PP&E (Net) | $205M | $271M | $383M | $818M | $800M | $644M | $542M | $510M | $407M | $376M | $328M | $314M | |
| PP&E (Gross) | $510M | $668M | $794M | $1.20B | $1.12B | $903M | $753M | $682M | $540M | $488M | $422M | $393M | |
| Accum. Depreciation | $304M | $397M | $411M | $384M | $319M | $259M | $210M | $172M | $132M | $112M | $94M | $79M | |
| Goodwill | $0 | $0 | $0 | $218M | $225M | $267M | $267M | $260M | $49M | $41M | $41M | $53M | |
| Intangibles | $436M | $502M | $567M | $729M | $605M | $663M | $713M | $762M | $120M | $34M | $41M | $58M | |
| Other Non-current Assets | $14M | $19M | $194M | $191M | $58M | $113M | $90M | $14M | $6M | $2M | $2M | $8M | |
| Total Assets | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Accounts Payable | $56M | $61M | $112M | $104M | $129M | $136M | $95M | $81M | $42M | $35M | $38M | $41M | |
| Accrued Liabilities | $12M | $18M | $19M | $35M | $52M | $47M | $40M | $31M | $5M | $6M | $6M | $6M | |
| Short-term Debt | · | $0 | $414M | $957M | $32M | $34M | $13M | $10M | $0 | $20M | $0 | · | |
| Current Liabilities | $132M | $162M | $651M | $1.23B | $374M | $384M | $216M | $200M | $100M | $106M | $100M | $93M | |
| Capital Leases | $9M | $10M | $14M | $15M | $24M | $28M | $22M | · | · | · | · | · | |
| Deferred Tax | $38M | $42M | $47M | $60M | $93M | $53M | $64M | $68M | $0 | · | · | · | |
| Other Non-current Liabilities | $54M | $39M | $29M | $42M | $70M | $68M | $49M | $49M | $5M | $2M | $1M | $1M | |
| Total Liabilities | $796M | $907M | $1.17B | $1.78B | $1.35B | $1.44B | $1.24B | $1.22B | $158M | $374M | $377M | $385M | |
| Long-term Debt | $590M | $700M | $868M | $1.41B | $850M | $886M | $822M | $809M | $14M | · | · | · | |
| Total Debt | $572M | $664M | $1.27B | · | $873M | $909M | $824M | $805M | $13M | $268M | $253M | $251M | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $41.0K | $40.0K | $38.0K | |
| Paid-in Capital | $942M | $928M | $904M | $874M | $829M | $785M | $716M | $689M | $618M | $352M | $318M | $274M | |
| Retained Earnings | $-160M | $-212M | $-22M | $739M | $950M | $727M | $422M | $367M | $337M | $254M | $351M | $288M | |
| Treasury Stock | $253M | $228M | $228M | $228M | $152M | $40M | $40M | $40M | $40M | $6M | $6M | $6M | |
| AOCI | $-8M | $-5M | $-6M | $3M | $-16M | $-25M | $-10M | $-6M | $-4M | $-4M | $-3M | $-3M | |
| Stockholders' Equity | $523M | $483M | $649M | $1.39B | $1.61B | $1.45B | $1.09B | $1.01B | $912M | $596M | $660M | $553M | |
| Liabilities + Equity | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Shares Outstanding | 52,100,000 | 54,300,000 | 52,200,000 | 50,100,000 | 51,300,000 | 54,300,000 | 51,700,000 | 51,200,000 | 49,400,000 | 41,000,000 | 39,800,000 | 38,129,872 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96M | $109M | $125M | $143M | $124M | $50M | $50M | $36M | $32M | $28M | $24M | $22M | |
| Stock-based Comp | $16M | $18M | $23M | $45M | $42M | $52M | $27M | $23M | $15M | $18M | $16M | $13M | |
| Deferred Tax | $-4M | $-6M | $-7M | $-34M | $43M | $-3M | $-1M | $9M | $3M | $5M | $3M | $16M | |
| Amort. of Intangibles | $65M | $65M | $66M | $60M | $58M | $60M | $59M | $25M | $9M | $7M | $7M | $7M | |
| Restructuring | $-2M | $22M | $29M | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $10M | $128M | $413M | · | · | $132M | $58M | $-89M | $75M | $-50M | $-62M | $23M | |
| Operating Cash Flow | $171M | $59M | $-206M | $-34M | $320M | $537M | $188M | $42M | $208M | $55M | $43M | $112M | |
| CapEx | $14M | $23M | $52M | $116M | $224M | $142M | $87M | $72M | $55M | $76M | $45M | $31M | |
| Investing Cash Flow | $69M | $125M | $212M | $-381M | $-224M | $-152M | $-97M | $-897M | $-250M | $-76M | $-45M | $-210M | |
| Debt Issued | · | · | · | · | · | · | · | $798M | $0 | $0 | $2M | $1M | |
| Net Debt Issued | · | · | · | · | · | · | · | $795M | $0 | $0 | $0 | $-62M | |
| Stock Issued | $0 | $0 | $8M | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $25M | $0 | $0 | $82M | $106M | $0 | $0 | $100.0K | $33M | $0 | $100.0K | $200.0K | |
| Net Stock Activity | $-25M | $0 | $8M | $-82M | $-106M | $0 | $0 | $-100.0K | $-33M | $0 | $-100.0K | $-200.0K | |
| Financing Cash Flow | $-137M | $-190M | $-536M | $481M | $-141M | $70M | $-36M | $789M | $-51M | $-20M | $35M | $199M | |
| Net Change in Cash | $104M | $-6M | $-531M | $66M | $-45M | $454M | $56M | $-67M | $-93M | $-41M | $32M | $101M | |
| Taxes Paid | $40M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $157M | $36M | $-258M | $-150M | $96M | $395M | $101M | $-30M | $153M | $-23M | $-353.0K | $82M | |
| Levered FCF | · | · | $-349M | $-186M | $71M | $372M | $74M | $-38M | $149M | $-28M | $-5M | $76M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 30.3% | 34.3% | · | · | · | · | · | · | · | · | |
| Operating Margin | 13.5% | -10.4% | -69.2% | -15.2% | 19.7% | 27.9% | 10.3% | 11.5% | 22.2% | 21.6% | 18.4% | 12.9% | |
| Net Margin | 7.1% | -18.3% | -72.5% | -18.9% | 12.9% | 19.6% | 4.9% | 8.0% | 14.7% | 10.6% | 12.0% | 8.2% | |
| Pretax Margin | 11.2% | -13.7% | -69.7% | -19.6% | 17.5% | 26.2% | 7.0% | 10.4% | 21.1% | 20.3% | 17.2% | 11.8% | |
| EBITDA Margin | 26.4% | 0.01% | -57.3% | -15.2% | 19.7% | 31.1% | 14.8% | 16.1% | 27.9% | 27.3% | 23.1% | 18.0% | |
| ROA | 3.9% | -11.9% | -30.5% | · | 7.9% | 11.7% | 2.4% | 3.8% | 8.1% | 5.2% | 6.4% | 4.7% | |
| ROE | 9.9% | -38.5% | -113.0% | · | 14.7% | 22.6% | 5.1% | 6.3% | 10.9% | 8.2% | 10.4% | 7.0% | |
| ROIC | 5.8% | -12.7% | -39.3% | · | 10.4% | 13.8% | 4.2% | 3.8% | 9.3% | 7.7% | 7.4% | 5.0% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 3.7 | 1.0 | · | 3.4 | 3.1 | 3.2 | 3.1 | 4.9 | 4.8 | 5.4 | 4.7 | |
| Quick Ratio | 2.2 | 1.6 | 0.5 | · | 2.3 | 2.2 | 2.0 | 1.9 | 3.2 | 3.9 | 4.4 | 3.7 | |
| Debt / Equity | 1.1 | 1.4 | 2.0 | · | 0.5 | 0.6 | 0.8 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| LT Debt / Equity | 1.1 | 1.4 | 0.7 | · | 0.5 | 0.6 | 0.7 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | -8.3 | -4.6 | 10.2 | 13.9 | 3.0 | 9.1 | 18.9 | 13.9 | 14.7 | 7.0 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.4 | · | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Inventory Turnover | 1.0 | · | 2.1 | · | · | 2.0 | 2.0 | 1.8 | 1.8 | 1.9 | 1.7 | 2.9 | |
| Receivables Turnover | 6.2 | 6.0 | 6.0 | · | 7.1 | 6.2 | 4.1 | 3.9 | 4.0 | 3.9 | 5.8 | 7.5 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.03 | $8.89 | $12.44 | · | $31.56 | $27.25 | $21.05 | $19.74 | $18.47 | $14.69 | $16.75 | $14.67 | |
| Revenue / Share | $13.10 | $19.69 | $20.49 | $22.31 | $33.14 | $28.91 | $21.11 | $15.22 | $11.14 | $9.91 | $11.06 | $9.83 | |
| Cash Flow / Share | $3.01 | $1.11 | $-4.03 | $-0.68 | $5.94 | $9.96 | $3.59 | $0.81 | $4.14 | $1.08 | $0.94 | $2.45 | |
| Cash / Share | $3.94 | $1.83 | $2.14 | · | $11.23 | $11.70 | $3.25 | $2.19 | $3.61 | $6.69 | $7.94 | $7.44 | |
| EPS (TTM) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -28.8% | -0.54% | -6.1% | -37.0% | 12.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.7% | -16.2% | -12.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | -28.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -30.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -28.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -29.7% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Net Income TTM | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| Market Cap | $644M | $519M | $125M | · | $2.23B | $4.76B | $2.79B | $3.04B | $2.30B | $1.33B | $1.58B | $1.03B | |
| Enterprise Value | $1.01B | $1.08B | $1.29B | · | $2.53B | $5.05B | $3.45B | $3.73B | $2.13B | $1.33B | $1.52B | $997M | |
| P/E | 13.3 | -2.7 | -0.2 | -2.8 | 10.7 | 15.8 | 51.9 | 48.6 | 27.2 | 29.1 | 28.4 | 30.9 | |
| P/S | 0.9 | 0.5 | 0.1 | · | 1.3 | 3.0 | 2.5 | 3.9 | 4.1 | 2.7 | 3.2 | 2.5 | |
| P/B | 1.2 | 1.1 | 0.2 | · | 1.4 | 3.3 | 2.6 | 3.0 | 2.5 | 2.2 | 2.4 | 1.9 | |
| P / Tangible Book | 7.5 | · | 1.5 | 1.3 | 2.9 | 9.1 | · | · | · | · | · | · | |
| P / Cash Flow | 3.8 | 8.8 | -0.6 | · | 6.9 | 8.9 | 14.8 | 72.6 | 11.0 | 24.9 | 35.5 | 9.1 | |
| P / FCF | 4.1 | 14.5 | -0.5 | · | 23.2 | 12.0 | 27.6 | -100.2 | 15.0 | -58.5 | -4466.5 | 12.6 | |
| EV / EBITDA | 5.2 | 10833.1 | -2.1 | · | 7.2 | 10.4 | 21.1 | 29.6 | 13.6 | 10.0 | 12.6 | 12.3 | |
| EV / FCF | 6.4 | 30.3 | -5.0 | · | 26.3 | 12.8 | 34.1 | -123.0 | 13.9 | -58.4 | -4297.1 | 12.2 | |
| EV / Revenue | 1.4 | 1.0 | 1.2 | · | 1.4 | 3.2 | 3.1 | 4.8 | 3.8 | 2.7 | 3.1 | 2.5 | |
| Earnings Yield | 7.5% | -37.7% | -618.8% | -35.7% | 9.3% | 6.3% | 1.9% | 2.1% | 3.7% | 3.4% | 3.5% | 3.2% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $234M | $156M | $149M | $231M | $141M | $222M | $195M | $294M | $255M | $300M | $277M | $270M | $338M | $164M | $330M | $240M | |
| Cost of Revenue | $97M | $72M | $85M | $86M | $67M | $88M | $118M | $123M | $296M | $145M | $185M | $177M | $191M | $153M | · | $147M | |
| Gross Profit | · | · | · | · | · | · | · | $161M | $-48M | $148M | · | $87M | $141M | $5M | · | $75M | |
| R&D Expense | $9M | $10M | $12M | $14M | $12M | $15M | $9M | $14M | $33M | $15M | $29M | $15M | $26M | $41M | $50M | $42M | |
| SG&A Expense | $45M | $47M | $51M | $39M | $44M | $52M | $61M | $77M | $86M | $85M | $90M | $86M | $91M | $101M | $92M | $82M | |
| Operating Income | $-125M | $10M | $-28M | $76M | $2M | $50M | $-10M | $64M | $-204M | $40M | $-44M | $-242M | $-293M | $-148M | $-55M | $-45M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $24M | · | $20M | $29M | $18M | · | $8M | |
| Other Non-op | $0 | $14M | $-8M | $-4M | $-4M | $70M | $-4M | $22M | $-3M | $-3M | $8M | $-3M | $-4M | $5M | $7M | $-13M | |
| Pretax Income | $-166M | $13M | $-51M | $58M | $-17M | $93M | $-28M | $142M | $-270M | $12M | $-54M | $-266M | $-250M | $-161M | $-65M | $-67M | |
| Income Tax | $14M | $7M | $4M | $6M | $-5M | $25M | $4M | $28M | $13M | $3M | $-5M | $-2M | $11M | $26M | $-800.0K | $20M | |
| Net Income | $-180M | $7M | $-55M | $51M | $-12M | $68M | $-31M | $115M | $-283M | $9M | $-50M | $-263M | $-261M | $-186M | $-67M | $-87M | |
| EPS (Basic) | $-3.49 | $0.13 | $-1.01 | $0.96 | $-0.22 | $1.25 | $-0.55 | $2.16 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| EPS (Diluted) | $-3.49 | $0.07 | $-0.95 | $0.91 | $-0.22 | $1.19 | $-0.45 | $2.06 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| Shares (Basic) | 51,600,000 | 51,900,000 | · | 53,200,000 | 54,200,000 | 54,400,000 | · | 53,100,000 | 52,600,000 | 52,200,000 | · | 51,800,000 | 50,700,000 | 50,200,000 | · | 49,900,000 | |
| Shares (Diluted) | 51,600,000 | 56,500,000 | · | 56,500,000 | 54,200,000 | 57,300,000 | · | 55,600,000 | 52,600,000 | 52,200,000 | · | 51,800,000 | 50,700,000 | 50,200,000 | · | 49,900,000 | |
| EBITDA | $-125M | $34M | · | $76M | $2M | $75M | · | $64M | $-204M | $68M | · | $-242M | $-293M | $-114M | · | $-42M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $140M | $160M | $205M | $246M | $267M | $149M | $100M | $150M | $70M | $78M | $112M | $88M | $89M | $430M | $643M | $241M | |
| Receivables | $190M | $122M | $84M | $150M | $80M | $204M | $154M | $121M | $196M | $234M | · | $216M | $290M | $156M | · | $191M | |
| Inventory | $304M | $328M | $343M | $356M | $339M | $314M | $312M | $323M | $318M | $333M | · | $354M | $354M | $368M | · | $546M | |
| Prepaid Expense | $25M | $27M | $26M | $26M | $24M | $30M | $27M | $61M | $36M | $36M | · | $62M | $45M | $42M | · | $140M | |
| Current Assets | $666M | $638M | $662M | $787M | $720M | $707M | $599M | $661M | $654M | $682M | · | $721M | $778M | $1.22B | · | $1.12B | |
| PP&E (Net) | $178M | $199M | $205M | $210M | $216M | $221M | $271M | $278M | $306M | $379M | · | $395M | $396M | $717M | · | $807M | |
| PP&E (Gross) | $475M | $509M | $510M | $500M | $516M | $518M | $668M | $672M | $707M | $802M | · | $796M | $787M | $1.09B | · | $1.17B | |
| Accum. Depreciation | $297M | $310M | $304M | $291M | $300M | $297M | $397M | $394M | $401M | $423M | · | $401M | $391M | $375M | · | $366M | |
| Goodwill | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $218M | $218M | · | $225M | |
| Intangibles | $262M | $470M | $436M | $453M | $469M | $485M | $502M | $518M | $534M | $550M | · | $583M | $593M | $609M | · | $723M | |
| Other Non-current Assets | $11M | $13M | $14M | $12M | $12M | $13M | $19M | $20M | $19M | $191M | · | $194M | $195M | $185M | · | $36M | |
| Total Assets | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Accounts Payable | $50M | $40M | $56M | $57M | $64M | $58M | $61M | $82M | $96M | $100M | · | $113M | $108M | $124M | · | $104M | |
| Accrued Liabilities | $17M | $9M | $12M | $14M | $14M | $13M | $18M | $16M | $17M | $14M | · | $17M | $31M | $21M | · | $36M | |
| Short-term Debt | · | · | · | · | · | · | · | $800.0K | $415M | $459M | · | $414M | $455M | $951M | · | $21M | |
| Current Liabilities | $123M | $149M | $132M | $136M | $127M | $112M | $162M | $230M | $620M | $630M | · | $664M | $693M | $1.22B | · | $268M | |
| Capital Leases | $5M | $9M | $9M | $6M | $6M | $5M | $10M | $11M | $12M | $13M | · | $15M | $13M | $13M | · | $16M | |
| Deferred Tax | $35M | $33M | $38M | $36M | $46M | $60M | $42M | $42M | $35M | $35M | · | $52M | $58M | $60M | · | $114M | |
| Other Non-current Liabilities | $35M | $42M | $54M | $43M | $40M | $35M | $39M | $36M | $26M | $28M | · | $31M | $23M | $24M | · | $45M | |
| Total Liabilities | $775M | $797M | $796M | $878M | $881M | $873M | $907M | $969M | $1.13B | $1.14B | · | $1.20B | $1.22B | $1.75B | · | $1.46B | |
| Long-term Debt | $590M | $590M | $590M | $693M | $700M | $700M | $700M | $701M | $864M | $909M | · | $866M | $909M | $1.41B | · | $1.06B | |
| Total Debt | $582M | $574M | · | $663M | $668M | $666M | · | $663M | $1.28B | $1.37B | · | $1.28B | $1.36B | $2.35B | · | $1.07B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $952M | $944M | $942M | $939M | $935M | $931M | $928M | $924M | $915M | $910M | · | $900M | $896M | $878M | · | $860M | |
| Retained Earnings | $-333M | $-153M | $-160M | $-105M | $-156M | $-144M | $-212M | $-181M | $-296M | $-13M | · | $28M | $290M | $551M | · | $822M | |
| Treasury Stock | $270M | $262M | $253M | $244M | $235M | $228M | $228M | $228M | $228M | $228M | · | $228M | $228M | $228M | · | $228M | |
| AOCI | $-7M | $-7M | $-8M | $-8M | $-8M | $-6M | $-5M | $-7M | $-6M | $-6M | · | $-3M | $-2M | $1M | · | $-5M | |
| Stockholders' Equity | $341M | $523M | $523M | $582M | $536M | $553M | $483M | $508M | $386M | $664M | $649M | $697M | $956M | $1.20B | $1.39B | $1.45B | |
| Liabilities + Equity | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Shares Outstanding | 51,300,000 | 51,800,000 | 52,100,000 | 52,700,000 | 53,700,000 | 54,500,000 | 54,300,000 | 54,100,000 | 52,900,000 | 52,400,000 | · | 51,800,000 | 51,800,000 | 50,400,000 | · | 49,900,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24M | $24M | $24M | $23M | $24M | $25M | $26M | $26M | $28M | $28M | $30M | $28M | $33M | $35M | $36M | $32M | |
| Stock-based Comp | $7M | $2M | $5M | $5M | $5M | $2M | $4M | $2M | $6M | $6M | $4M | $4M | $8M | $7M | $12M | $11M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-57M | $20M | |
| Amort. of Intangibles | $17M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $17M | $18M | $14M | |
| Restructuring | · | · | $0 | $300.0K | $-1M | $-1M | $-400.0K | $6M | $17M | $-500.0K | $-600.0K | $20M | $-100.0K | $10M | · | · | |
| Other Non-cash | · | $-66M | · | · | · | $-106M | · | · | · | $-105M | · | · | · | $-42M | · | · | |
| Operating Cash Flow | $56M | $-34M | $78M | $-2M | $106M | $-11M | $-80M | $154M | $48M | $-63M | $32M | $60M | $-114M | $-184M | $93M | $-74M | |
| CapEx | $2M | $2M | $4M | $3M | $3M | $4M | $2M | $6M | $5M | $11M | $11M | $13M | $12M | $15M | $24M | $28M | |
| Investing Cash Flow | $-52M | $-2M | $-4M | $-3M | $17M | $60M | $29M | $112M | $-5M | $-11M | $-11M | $-19M | $258M | $-15M | $-45M | $-272M | |
| Stock Issued | · | $400.0K | $-1M | · | · | $0 | $0 | $0 | · | · | $200.0K | $0 | · | · | $0 | $0 | |
| Stock Repurchased | $9M | $9M | $9M | $9M | $7M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $200.0K | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-24M | $-11M | $-114M | $-16M | $-6M | $-400.0K | $500.0K | $-180M | $-51M | $41M | $5M | $-43M | $-487M | $-10M | $353M | $229M | |
| Net Change in Cash | $-21M | $-48M | $-40M | $-22M | $118M | $47M | $-51M | $85M | $-8M | $-33M | $24M | $-800.0K | $-344M | $-210M | $402M | $-117M | |
| Free Cash Flow | · | $-36M | · | · | · | $-15M | · | · | · | $-73M | · | · | · | $-199M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-91M | · | · | · | $-219M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 54.9% | -18.9% | 49.2% | · | 32.2% | 41.6% | 2.1% | · | 30.8% | |
| Operating Margin | -53.4% | 6.7% | · | 33.1% | 1.1% | 22.5% | · | 21.9% | -79.9% | 13.2% | · | -89.5% | -86.7% | -89.7% | · | -17.5% | |
| Net Margin | -76.9% | 4.4% | · | 22.1% | -8.5% | 30.6% | · | 39.1% | -111.1% | 3.0% | · | -97.4% | -77.3% | -110.8% | · | -31.5% | |
| Pretax Margin | -71.0% | 8.6% | · | 24.9% | -11.9% | 41.7% | · | 48.5% | -105.9% | 4.0% | · | -98.3% | -74.1% | -97.6% | · | -26.6% | |
| EBITDA Margin | -53.4% | 21.8% | · | 33.1% | 1.1% | 33.9% | · | 21.9% | -79.9% | 22.5% | · | -89.5% | -86.7% | -68.8% | · | -17.5% | |
| ROA | -14.2% | 0.50% | · | 3.5% | -0.82% | 4.2% | · | 6.8% | -15.3% | 0.38% | · | -11.0% | -10.6% | -6.4% | · | -2.6% | |
| ROE | -41.1% | 1.3% | · | 9.4% | -2.6% | 11.2% | · | 19.0% | -42.2% | 0.96% | · | -24.5% | -21.2% | -13.2% | · | -5.1% | |
| ROIC | -14.7% | 0.49% | · | 5.5% | 0.09% | 3.0% | · | 4.4% | -12.8% | 1.5% | · | -12.2% | -13.2% | -4.7% | · | -2.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 4.3 | · | 5.8 | 5.7 | 6.3 | · | 2.9 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 4.2 | |
| Quick Ratio | 2.7 | 1.9 | · | 2.9 | 2.7 | 3.2 | · | 1.2 | 0.4 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 1.6 | |
| Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 3.3 | 2.1 | · | 1.8 | 1.4 | 2.0 | · | 0.7 | |
| LT Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 1.2 | 0.7 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 1.6 | · | -12.3 | -10.2 | -8.3 | · | -4.9 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 0.9 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | · | |
| Receivables Turnover | 1.7 | 1.0 | · | 1.7 | 1.0 | 1.0 | · | 1.7 | 1.0 | 1.5 | · | 1.3 | 1.5 | 1.0 | · | 1.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.66 | $10.10 | · | $11.05 | $9.99 | $10.14 | · | $9.40 | $7.30 | $12.67 | · | $13.46 | $18.46 | $23.86 | · | $29.04 | |
| Revenue / Share | $4.54 | $2.76 | · | $4.09 | $2.60 | $3.88 | · | $5.28 | $4.84 | $5.75 | · | $5.22 | $6.66 | $3.29 | · | $4.81 | |
| Cash Flow / Share | · | $-0.60 | · | · | · | $-0.20 | · | · | · | $-1.20 | · | · | · | $-3.67 | · | · | |
| Cash / Share | $2.72 | $3.09 | · | $4.66 | $4.98 | $2.74 | · | $2.77 | $1.32 | $1.50 | · | $1.70 | $1.71 | $8.54 | · | $4.83 | |
| EPS (TTM) | $-3.46 | $-0.19 | · | $1.43 | $2.58 | $-2.58 | · | $-4.05 | $-11.19 | $-10.97 | · | $-15.27 | $-11.94 | $-7.84 | · | $0.40 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $770M | $677M | · | $789M | $852M | $965M | · | $1.13B | $1.10B | $1.19B | · | $1.10B | $1.07B | $977M | · | $1.49B | |
| Net Income TTM | $-177M | $-9M | · | $76M | $140M | $-132M | · | $-209M | $-587M | $-565M | · | $-778M | $-602M | $-393M | · | $33M | |
| Market Cap | $430M | $430M | · | $465M | $343M | $265M | · | $452M | $361M | $133M | · | $176M | $381M | $522M | · | $1.05B | |
| Enterprise Value | $872M | $843M | · | $882M | $743M | $781M | · | $965M | $1.57B | $1.42B | · | $1.36B | $1.65B | $2.44B | · | $1.88B | |
| P/E | -2.4 | -43.7 | · | 6.2 | 2.5 | -1.9 | · | -2.1 | -0.6 | -0.2 | · | -0.2 | -0.6 | -1.3 | · | 52.5 | |
| P/S | 0.6 | 0.6 | · | 0.6 | 0.4 | 0.3 | · | 0.4 | 0.3 | 0.1 | · | 0.2 | 0.4 | 0.5 | · | 0.7 | |
| P/B | 1.3 | 0.8 | · | 0.8 | 0.6 | 0.5 | · | 0.9 | 0.9 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.7 | |
| P / Tangible Book | 5.4 | 8.2 | · | 3.6 | 5.1 | 3.9 | · | · | · | 1.2 | · | 1.5 | 2.6 | 1.4 | · | 2.1 | |
| P / Cash Flow | · | -12.7 | · | · | · | -23.6 | · | · | · | -2.1 | · | · | · | -2.8 | · | · | |
| EV / Revenue | 1.1 | 1.2 | · | 1.1 | 0.9 | 0.8 | · | 0.9 | 1.4 | 1.2 | · | 1.2 | 1.5 | 2.5 | · | 1.3 | |
| Earnings Yield | -41.3% | -2.3% | · | 16.2% | 40.4% | -53.1% | · | -48.5% | -164.1% | -433.6% | · | -449.1% | -162.5% | -75.7% | · | 1.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Umsatz | $743M | $1.04B | $1.05B | $1.12B | · |
| Bruttogewinnmarge % | · | · | 30.3% | 34.3% | · |
| Betriebsgewinnmarge % | 13.5% | -10.4% | -69.2% | -15.2% | · |
| Nettoergebnis | $53M | $-191M | $-760M | $-212M | · |
| Verwässerte EPS | $0.93 | $-3.60 | $-14.85 | $-4.22 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 1.1 | 1.4 | 2.0 | · | · |
| Liquiditätsgrad | 5.0 | 3.7 | 1.0 | · | · |
| Quick Ratio | 2.2 | 1.6 | 0.5 | · | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Freier Cashflow | $157M | $36M | $-258M | $-150M | · |
Institutionelle Eigentümer (13F) 209 Einreicher · $391.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
209
Gehaltener Wert
$391.0M
Neue Positionen
31
Geschlossene Positionen
24
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 31 (-7 vs. Vorquartal) | 24 (+1 vs. Vorquartal) | 71 (+1 vs. Vorquartal) | 63 (+9 vs. Vorquartal) | +916K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $43.927.428 | 3.553.999 | 11,23% | Aktien |
| BlackRock, Inc. | $39.525.100 | 4.716.599 | 10,11% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $25.782.865 | 3.076.646 | 6,59% | Aktien |
| STATE STREET CORP | $24.556.367 | 2.929.238 | 6,28% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $23.216.354 | 2.770.448 | 5,94% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $18.426.271 | 2.198.839 | 4,71% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $11.208.910 | 1.337.243 | 2,87% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10.062.629 | 1.200.791 | 2,57% | Aktien |
| OAK HILL ADVISORS LP | $9.329.772 | 1.113.338 | 2,39% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $8.984.910 | 1.072.185 | 2,30% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $8.724.846 | 1.041.151 | 2,23% | Aktien |
| GOLDMAN SACHS GROUP INC | $8.676.828 | 1.035.421 | 2,22% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8.626.129 | 1.029.371 | 2,21% | Aktien |
| D. E. Shaw & Co., Inc. | $7.542.905 | 900.108 | 1,93% | Aktien |
| Russell Investments Group, Ltd. | $7.202.462 | 859.482 | 1,84% | Aktien |
| FEDERATED HERMES, INC. | $6.964.828 | 831.125 | 1,78% | Aktien |
| PRUDENTIAL FINANCIAL INC | $6.753.400 | 805.895 | 1,73% | Aktien |
| Prescott Group Capital Management, L.L.C. | $6.475.821 | 772.771 | 1,66% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $5.725.610 | 683.247 | 1,46% | Aktien |
| NORTHERN TRUST CORP | $5.207.944 | 621.473 | 1,33% | Aktien |
| Allianz Asset Management GmbH | $4.556.885 | 543.781 | 1,17% | Aktien |
| PALISADE CAPITAL MANAGEMENT, LP | $4.316.191 | 515.059 | 1,10% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $4.306.516 | 513.904 | 1,10% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $4.091.820 | 488.284 | 1,05% | Aktien |
| MORGAN STANLEY | $3.936.225 | 469.715 | 1,01% | Aktien |
| Prosight Management, LP | $3.854.398 | 459.952 | 0,99% | Aktien |
| Trexquant Investment LP | $3.753.050 | 447.858 | 0,96% | Aktien |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3.690.745 | 440.423 | 0,94% | Aktien |
| UBS Group AG | $3.067.172 | 366.011 | 0,78% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $2.966.378 | 353.983 | 0,76% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.863.614 | 341.720 | 0,73% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $2.757.523 | 329.060 | 0,71% | Aktien |
| Values First Advisors, Inc. | $2.526.468 | 301.488 | 0,65% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.420.144 | 288.800 | 0,62% | Kaufoption |
| GLOBEFLEX CAPITAL L P | $2.022.077 | 241.298 | 0,52% | Aktien |
| Bank of New York Mellon Corp | $1.840.760 | 219.661 | 0,47% | Aktien |
| FMR LLC | $1.794.733 | 214.169 | 0,46% | Aktien |
| Brandywine Global Investment Management, LLC | $1.610.632 | 130.310 | 0,41% | Aktien |
| DEUTSCHE BANK AG\ | $1.591.513 | 189.918 | 0,41% | Aktien |
| Morse Asset Management, Inc | $1.536.339 | 183.334 | 0,39% | Aktien |
| WOLVERINE ASSET MANAGEMENT LLC | $1.465.939 | 174.933 | 0,37% | Aktien |
| FRANKLIN RESOURCES INC | $1.398.144 | 166.843 | 0,36% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $1.390.066 | 165.879 | 0,36% | Aktien |
| ARISTEIA CAPITAL, L.L.C. | $1.355.490 | 161.753 | 0,35% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.275.596 | 152.219 | 0,33% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.273.476 | 151.966 | 0,33% | Aktien |
| Squarepoint Ops LLC | $1.240.374 | 148.016 | 0,32% | Aktien |
| CREDIT AGRICOLE S A | $1.225.994 | 146.300 | 0,31% | Aktien |
| Invesco Ltd. | $1.224.024 | 146.065 | 0,31% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1.028.000 | 122.700 | 0,26% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. | 23. August 2010 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 48 Insider · 12 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel Abdun-Nabi | CEO | 4. März 2019 S | 142.617 | 0 | 0 | $0 |
| Richard S Lindahl | EVP, Chief Financial Officer | 8. Juni 2026 F | 374.083 | 0 | 0 | $0 |
| Don R Elsey | Chief Financial Officer | 13. März 2012 A | 26.614 | 0 | 0 | $0 |
| Paul Anthony Williams | SVP, Products Business | 1. Juli 2026 S | 159.098 | 0 | 2 | $-58.960 |
| William Hartzel | SVP, Bioservices | 8. Juni 2026 F | 185.558 | 0 | 0 | $0 |
| Coleen Glessner | EVP, Quality & Ethics, and CPL | 8. Juni 2026 F | 202.201 | 0 | 1 | $-306.080 |
| Simon C Lowry | SVP, R&D, CMO | 29. April 2026 A | 177.914 | 0 | 0 | $0 |
| Jessica Perl | SVP, General Counsel, Corp Sec | 29. April 2026 A | 165.286 | 0 | 0 | $0 |
| Barry Labinger | EVP, Biosciences Div. | 13. November 2015 S | 25.182 | 0 | 0 | $0 |
| Steven Chatfield | EVP, BioSciences | 14. März 2013 F | 28.000 | 0 | 0 | $0 |
| Kyle Keese | EVP, BioSciences Division | 15. März 2011 A | 18.759 | 0 | 0 | $0 |
| Stephen Lockhart | SVP Product Development | 11. November 2010 M | 6.980 | 0 | 0 | $0 |
| Kathryn C Zoon | Direktor | 30. April 2026 A | 79.941 | 0 | 2 | $-144.453 |
| Donald W Degolyer | Direktor | 30. April 2026 A | 129.721 | 0 | 3 | $-317.617 |
| Sujata Tyagi Dayal | Direktor | 30. April 2026 A | 100.563 | 0 | 3 | $-201.130 |
| Neal Franklin Fowler | Direktor | 30. April 2026 A | 160.847 | 0 | 0 | $0 |
| Marvin L White | Direktor | 30. April 2026 A | 113.839 | 0 | 0 | $0 |
| John D Fowler JR | Direktor | 30. April 2026 A | 30.350 | 0 | 0 | $0 |
| Fuad El-Hibri | Direktor | 3. Dezember 2021 J | 206.434 | 0 | 0 | $0 |
| Seamus Mulligan | Direktor | 19. März 2019 A | 56.141 | 0 | 0 | $0 |
| John Niederhuber | Direktor | 18. Mai 2016 D | 30.300 | 0 | 0 | $0 |
| Shahzad Malik | Direktor | 14. Juni 2007 A | · | 0 | 0 | $0 |
| Intervac, L.L.C. | 10%-Eigentümer | 18. September 2012 J | 4.344.250 | 0 | 0 | $0 |
| BioPharm, L.L.C. | 10%-Eigentümer | 27. Mai 2010 J | 2.265.043 | 0 | 0 | $0 |
| Microscience Investments LTD | 10%-Eigentümer | 8. März 2007 J | 0 | 0 | 0 | $0 |
| Zsolt Harsanyi | · | 30. April 2026 A | 149.076 | 0 | 0 | $0 |
| Ronald Richard | · | 30. April 2026 A | 123.761 | 0 | 2 | $-263.101 |
| Keith Katkin | · | 30. April 2026 A | 96.294 | 0 | 1 | $-128.183 |
| Joseph C Papa | · | 29. April 2026 A | 493.153 | 0 | 0 | $0 |
| Louis W Sullivan | · | 30. April 2025 A | 139.098 | 0 | 0 | $0 |
| Jennifer Lynne Fox | · | 11. Juli 2024 A | 186.382 | 0 | 0 | $0 |
| Adam Havey | · | 9. Juni 2023 A | 174.398 | 0 | 0 | $0 |
| Robert Kramer | · | 9. Juni 2023 A | 506.059 | 0 | 0 | $0 |
| Jerome M Hauer | · | 25. Mai 2023 A | 57.508 | 0 | 0 | $0 |
| Katherine Strei | · | 28. Februar 2023 F | 62.824 | 0 | 0 | $0 |
| Atul Saran | · | 28. Februar 2023 F | 86.645 | 0 | 0 | $0 |
| George A Joulwan | · | 26. Mai 2022 A | 40.244 | 0 | 0 | $0 |
| Karen L. Smith | · | 7. Mai 2021 F | 11.888 | 0 | 0 | $0 |
| Sean Kirk | · | 31. März 2021 F | 17.776 | 0 | 0 | $0 |
| Sue Bailey | · | 4. März 2021 S | 24.427 | 0 | 0 | $0 |
| Denise Esposito | · | 10. März 2009 A | 500 | 0 | 0 | $0 |
| Biologika, L.L.C. | · | 4. Juni 2008 S | 1.399.764 | 0 | 0 | $0 |
| Joe M Allbaugh | · | 21. Mai 2008 A | · | 0 | 0 | $0 |
| Michigan Biologic Products, Inc. | · | 28. März 2008 S | 1.269.390 | 0 | 0 | $0 |
| Mauro Gibellini | · | 4. Juni 2007 S | 0 | 0 | 0 | $0 |
| Thomas Zink | · | 17. Mai 2007 P | 1.000 | 0 | 0 | $0 |
| Edward Arcuri | · | 8. Mai 2007 M | 76.722 | 0 | 0 | $0 |
| Robert Calvin Myers | · | 20. November 2006 C | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 61 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| EWO · iShares, Inc. | 23,05% | 335.709 SH | 11. September 2026 | Täglich |
| EUFN · iShares Trust | 1,19% | 353.714 SH | 11. September 2026 | Täglich |
| MTRA · Invesco Actively Managed Exchange-T… | 1,14% | 11.292 SH | 1. Oktober 2026 | Täglich |
| MYLD · Cambria ETF Trust | 0,87% | 41.046 NS | 31. Juli 2026 | N-PORT |
| PIZ · Invesco Exchange-Traded Fund Trust … | 0,69% | 33.118 SH | 1. Oktober 2026 | Täglich |
| EZU · iShares, Inc. | 0,57% | 390.787 SH | 11. September 2026 | Täglich |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,40% | 3.381.000 | 1. Oktober 2026 | Täglich |
| DMXF · iShares Trust | 0,40% | 26.552 SH | 11. September 2026 | Täglich |
| IEV · iShares Trust | 0,32% | 37.421 SH | 11. September 2026 | Täglich |
| IVLU · iShares Trust | 0,31% | 102.055 SH | 11. September 2026 | Täglich |
| IXG · iShares Trust | 0,28% | 13.907 SH | 11. September 2026 | Täglich |
| IEUR · iShares Trust | 0,28% | 179.129 SH | 11. September 2026 | Täglich |
| IMTM · iShares Trust | 0,25% | 77.739 SH | 11. September 2026 | Täglich |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,24% | 673.051 SH | 19. August 2026 | Täglich |
| PABD · iShares Trust | 0,23% | 5.313 SH | 11. September 2026 | Täglich |
| EFG · iShares Trust | 0,20% | 236.854 SH | 11. September 2026 | Täglich |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,20% | 312.634 SH | 19. August 2026 | Täglich |
| EFA · iShares Trust | 0,20% | 1.097.211 SH | 11. September 2026 | Täglich |
| EFV · iShares Trust | 0,20% | 436.714 SH | 11. September 2026 | Täglich |
| IEFA · iShares Trust | 0,17% | 2.312.794 SH | 11. September 2026 | Täglich |
| IDEV · iShares Trust | 0,15% | 343.523 SH | 11. September 2026 | Täglich |
| ESGD · iShares Trust | 0,14% | 123.676 SH | 11. September 2026 | Täglich |
| ACWX · iShares Trust | 0,12% | 101.401 SH | 11. September 2026 | Täglich |
| PXF · Invesco Exchange-Traded Fund Trust … | 0,11% | 23.661 SH | 1. Oktober 2026 | Täglich |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,11% | 2.737.509 SH | 19. August 2026 | Täglich |
| VSGX · VANGUARD WORLD FUND | 0,11% | 56.354 SH | 19. August 2026 | Täglich |
| IXUS · iShares Trust | 0,10% | 431.754 SH | 11. September 2026 | Täglich |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,09% | 655.464 SH | 19. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,08% | 57.978 NS | 31. Juli 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,08% | 4.120.164 SH | 19. August 2026 | Täglich |
| IWC · iShares Trust | 0,07% | 175.885 SH | 11. September 2026 | Täglich |
| TOK · iShares Trust | 0,05% | 841 SH | 11. September 2026 | Täglich |
| URTH · iShares, Inc. | 0,05% | 28.175 SH | 11. September 2026 | Täglich |
| ACWI · iShares Trust | 0,04% | 100.105 SH | 11. September 2026 | Täglich |
| IMFL · Invesco Exchange-Traded Self-Indexe… | 0,04% | 2.979 SH | 1. Oktober 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 242.129 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 45.382 SH | 19. August 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,03% | 304.251 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 105.903 SH | 1. Oktober 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,02% | 792 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,02% | 366.188 SH | 11. September 2026 | Täglich |
| DFAT · Dimensional ETF Trust | 0,02% | 374.907 NS | 31. Juli 2026 | N-PORT |
| CRBN · iShares Trust | 0,02% | 1.504 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 24.878 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.357.340 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 299.394 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 151.590 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 170.332 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2.757 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 140.649 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.377 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 2.661 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 18.981 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.026 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 56.305 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 14.557 SH | 4. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 592.580 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.554.116 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.439 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 499.316 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 279.031 SH | 11. September 2026 | Täglich |
EBS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 7 Analysten
KAUF
Median-Ziel
$11.00
+73,8%
1 14,3%
Starker Kauf
4 57,1%
Kauf
1 14,3%
Halten
1 14,3%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-09-28Mittelwert-Ziel $11.00 +73,8%
← Unter allen Zielen
Aktueller Preis $6.33
Tief$10.00
Mittelwert$11.00
Hoch$12.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | · |
| SRZN | · | · | · | · | · | · |
| CYPH | $97M | 16.6 | · | · | 6.1% | · |
| ARTV | · | -1.3 | -99.2% | · | · | · |
| SCTX | · | · | · | · | · | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| LRMR | $317M | -2.2 | · | · | -167.4% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026